Shiokawa Y - Search Results

1

Hepatosplenic γδ T Cell Lymphoma Involving the Brain.

Iijima S, Chiba T, Maruyama K, Saito K, Kobayashi K, Yamagishi Y, Shibahara J, Takayama N, Shiokawa Y, Nagane M. Iijima S, et al. Among authors: shiokawa y. World Neurosurg. 2018 Oct;118:139-142. doi: 10.1016/j.wneu.2018.07.048. Epub 2018 Jul 18. World Neurosurg. 2018. PMID: 30030187

2

Meningeal melanocytoma associated with ipsilateral nevus of Ota presenting as intracerebral hemorrhage: case report.

Hino K, Nagane M, Fujioka Y, Shiokawa Y. Hino K, et al. Among authors: shiokawa y. Neurosurgery. 2005 Jun;56(6):E1376; discussion E1376. doi: 10.1227/01.neu.0000159716.45457.bc. Neurosurgery. 2005. PMID: 15918956

3

Synergistic cytotoxicity through the activation of multiple apoptosis pathways in human glioma cells induced by combined treatment with ionizing radiation and tumor necrosis factor-related apoptosis-inducing ligand.

Nagane M, Cavenee WK, Shiokawa Y. Nagane M, et al. Among authors: shiokawa y. J Neurosurg. 2007 Mar;106(3):407-16. doi: 10.3171/jns.2007.106.3.407. J Neurosurg. 2007. PMID: 17367063

4

Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.

Kobayashi K, Ohnishi A, Promsuk J, Shimizu S, Kanai Y, Shiokawa Y, Nagane M. Kobayashi K, et al. Among authors: shiokawa y. Neurosurgery. 2008 Feb;62(2):493-503; discussion 503-4. doi: 10.1227/01.neu.0000316018.51292.19. Neurosurgery. 2008. PMID: 18382329

5

Outcomes of chronic subdural hematoma with preexisting comorbidities causing disturbed consciousness.

Abe Y, Maruyama K, Yokoya S, Noguchi A, Sato E, Nagane M, Shiokawa Y. Abe Y, et al. Among authors: shiokawa y. J Neurosurg. 2017 Apr;126(4):1042-1046. doi: 10.3171/2016.3.JNS152957. Epub 2016 May 27. J Neurosurg. 2017. PMID: 27231976

6

Black hairy tongue after chemotherapy for malignant brain tumors.

Yamagishi Y, Maruyama K, Kobayashi K, Kume S, Sasaki N, Yokoya S, Saito K, Shiokawa Y, Nagane M. Yamagishi Y, et al. Among authors: shiokawa y. Acta Neurochir (Wien). 2017 Jan;159(1):169-172. doi: 10.1007/s00701-016-3036-5. Epub 2016 Nov 23. Acta Neurochir (Wien). 2017. PMID: 27878617

7

Smart Glasses for Neurosurgical Navigation by Augmented Reality.

Maruyama K, Watanabe E, Kin T, Saito K, Kumakiri A, Noguchi A, Nagane M, Shiokawa Y. Maruyama K, et al. Among authors: shiokawa y. Oper Neurosurg (Hagerstown). 2018 Nov 1;15(5):551-556. doi: 10.1093/ons/opx279. Oper Neurosurg (Hagerstown). 2018. PMID: 29373710

8

Consecutive single-institution case series of primary central nervous system lymphoma treated by R-MPV or high-dose methotrexate monotherapy.

Sasaki N, Kobayashi K, Saito K, Shimizu S, Suzuki K, Lee J, Yamagishi Y, Shibahara J, Takayama N, Shiokawa Y, Nagane M. Sasaki N, et al. Among authors: shiokawa y. Jpn J Clin Oncol. 2020 Sep 5;50(9):999-1008. doi: 10.1093/jjco/hyaa073. Jpn J Clin Oncol. 2020. PMID: 32469065

9

Prognostic factors for primary central nervous system lymphomas treated with high-dose methotrexate-based chemo-radiotherapy.

Lee J, Shishido-Hara Y, Suzuki K, Shimizu S, Kobayashi K, Kamma H, Shiokawa Y, Nagane M. Lee J, et al. Among authors: shiokawa y. Jpn J Clin Oncol. 2017 Oct 1;47(10):925-934. doi: 10.1093/jjco/hyx098. Jpn J Clin Oncol. 2017. PMID: 28981733

10

Survival in patients with glioblastoma at a first progression does not correlate with isocitrate dehydrogenase (IDH)1 gene mutation status.

Tabei Y, Kobayashi K, Saito K, Shimizu S, Suzuki K, Sasaki N, Shiokawa Y, Nagane M. Tabei Y, et al. Among authors: shiokawa y. Jpn J Clin Oncol. 2021 Jan 1;51(1):45-53. doi: 10.1093/jjco/hyaa162. Jpn J Clin Oncol. 2021. PMID: 32888020 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

564 results

Search Page